Sean P. Nolan

TSHA

Sean P. Nolan serves as Chief Executive Officer at Taysha Gene Therapies, Inc. (TSHA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$426.1K

Total Sells

1 trades

$840.2K

Net Position

Net Seller

$414.0K

Companies Traded

TSHA

Active Period

May 2021 – Jan 2026

3 total trades

Most Recent

Sell TSHA

Jan 23, 2026 · $840.2K

Sean P. Nolan's Insider Trading at Taysha Gene Therapies, Inc. (TSHA)

Buys

2 · $426.1K

Sells

1 · $840.2K

Total Shares Bought

445,614

Total Shares Sold

178,101

TSHA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 23, 2026	Sell	178,101	$4.72	$840.2K	0
Aug 16, 2023	Buy	444,444	$0.90	$400.0K	1,535,545
May 24, 2021	Buy	1,170	$22.35	$26.1K	1,170

Related Insiders

Kamran Alam

CHIEF FINANCIAL OFFICER

TSHASell · Feb 4, 2026

Sukumar Nagendran

President and Head of R&D

TSHASell · Jan 23, 2026

Paul B Manning

10% Owner

TSHABuy · May 30, 2025

Explore More Insider Trading Data

TSHA Insider Trading Activity

View all insider trades at Taysha Gene Therapies, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity